Osako MK - Search Results

1

Cross-talk of receptor activator of nuclear factor-κB ligand signaling with renin-angiotensin system in vascular calcification.

Osako MK, Nakagami H, Shimamura M, Koriyama H, Nakagami F, Shimizu H, Miyake T, Yoshizumi M, Rakugi H, Morishita R. Osako MK, et al. Arterioscler Thromb Vasc Biol. 2013 Jun;33(6):1287-96. doi: 10.1161/ATVBAHA.112.301099. Epub 2013 Apr 11. Arterioscler Thromb Vasc Biol. 2013. PMID: 23580147

2

Estrogen inhibits vascular calcification via vascular RANKL system: common mechanism of osteoporosis and vascular calcification.

Osako MK, Nakagami H, Koibuchi N, Shimizu H, Nakagami F, Koriyama H, Shimamura M, Miyake T, Rakugi H, Morishita R. Osako MK, et al. Circ Res. 2010 Aug 20;107(4):466-75. doi: 10.1161/CIRCRESAHA.110.216846. Epub 2010 Jul 1. Circ Res. 2010. PMID: 20595654

3

Potential effect of angiotensin II receptor blockade in adipose tissue and bone.

Nakagami H, Osako MK, Morishita R. Nakagami H, et al. Among authors: osako mk. Curr Pharm Des. 2013;19(17):3049-53. doi: 10.2174/1381612811319170011. Curr Pharm Des. 2013. PMID: 23176218 Review.

4

New concept of vascular calcification and metabolism.

Nakagami H, Osako MK, Morishita R. Nakagami H, et al. Among authors: osako mk. Curr Vasc Pharmacol. 2011 Jan;9(1):124-7. doi: 10.2174/157016111793744742. Curr Vasc Pharmacol. 2011. PMID: 21044018 Review.

5

OPG/RANKL/RANK axis is a critical inflammatory signaling system in ischemic brain in mice.

Shimamura M, Nakagami H, Osako MK, Kurinami H, Koriyama H, Zhengda P, Tomioka H, Tenma A, Wakayama K, Morishita R. Shimamura M, et al. Among authors: osako mk. Proc Natl Acad Sci U S A. 2014 Jun 3;111(22):8191-6. doi: 10.1073/pnas.1400544111. Epub 2014 May 20. Proc Natl Acad Sci U S A. 2014. PMID: 24847069 Free PMC article.

6

Angiotensin II accelerates osteoporosis by activating osteoclasts.

Shimizu H, Nakagami H, Osako MK, Hanayama R, Kunugiza Y, Kizawa T, Tomita T, Yoshikawa H, Ogihara T, Morishita R. Shimizu H, et al. Among authors: osako mk. FASEB J. 2008 Jul;22(7):2465-75. doi: 10.1096/fj.07-098954. Epub 2008 Feb 6. FASEB J. 2008. PMID: 18256306

7

Vascular protective effects of ezetimibe in ApoE-deficient mice.

Nakagami H, Osako MK, Takami Y, Hanayama R, Koriyama H, Mori M, Hayashi H, Shimizu H, Morishita R. Nakagami H, et al. Among authors: osako mk. Atherosclerosis. 2009 Mar;203(1):51-8. doi: 10.1016/j.atherosclerosis.2008.05.026. Epub 2008 May 27. Atherosclerosis. 2009. PMID: 18603252

8

Prevention of osteoporosis by angiotensin-converting enzyme inhibitor in spontaneous hypertensive rats.

Shimizu H, Nakagami H, Osako MK, Nakagami F, Kunugiza Y, Tomita T, Yoshikawa H, Rakugi H, Ogihara T, Morishita R. Shimizu H, et al. Among authors: osako mk. Hypertens Res. 2009 Sep;32(9):786-90. doi: 10.1038/hr.2009.99. Epub 2009 Jul 10. Hypertens Res. 2009. PMID: 19590507

9

Estrogen attenuates vascular remodeling in Lp(a) transgenic mice.

Nakagami F, Nakagami H, Osako MK, Iwabayashi M, Taniyama Y, Doi T, Shimizu H, Shimamura M, Rakugi H, Morishita R. Nakagami F, et al. Among authors: osako mk. Atherosclerosis. 2010 Jul;211(1):41-7. doi: 10.1016/j.atherosclerosis.2010.01.016. Epub 2010 Jan 25. Atherosclerosis. 2010. PMID: 20138621

10

Differential response of vascular hepatocyte growth factor concentration and lipid accumulation between telmisartan and losartan in ApoE-deficient mice.

Nakagami H, Osako MK, Takami Y, Hanayama R, Koriyama H, Mori M, Hayashi H, Shimizu H, Morishita R. Nakagami H, et al. Among authors: osako mk. Mol Med Rep. 2008 Sep-Oct;1(5):657-61. doi: 10.3892/mmr_00000008. Mol Med Rep. 2008. PMID: 21479465

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page